<?xml version="1.0" encoding="UTF-8"?>
<p>To determine whether VGCV prevented pathology by inhibiting Ad replication in target organs, liver, lungs, and kidney samples were collected at necropsy and analyzed for infectious virus burden. Vehicle-treated Ad-infected animals had a very high virus burden in all of the tested organs (
 <xref ref-type="fig" rid="viruses-09-00147-f002">Figure 2</xref>), with the Ad6 burden being generally higher than Ad5. VGCV treatment reduced the virus burden in all three organs for both Ad5- and Ad6-infected hamsters. Remarkably, VGCV reduced the Ad6 virus burden to undetectable levels (
 <xref ref-type="fig" rid="viruses-09-00147-f002">Figure 2</xref>).
</p>
